Chimeric Antigen Receptor-Modified Immune Effector Cell Therapies: Learning From the Present; Charting a Path to the Future

Cancer J. 2021 Mar-Apr;27(2):90-91. doi: 10.1097/PPO.0000000000000518.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Humans
  • Immunotherapy, Adoptive*
  • Neoplasms* / therapy
  • Receptors, Antigen, T-Cell / genetics
  • Receptors, Chimeric Antigen* / genetics


  • Receptors, Antigen, T-Cell
  • Receptors, Chimeric Antigen